))
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
…
continue reading
1
Navigating the Complexities of Access to Specialty Medications with Chelsey Lindner Shields Health Solutions TRANSCRIPT
Chelsey Lindner, a pharmacist and Manager of Clinical Services at Shields Health Solutions, provides insights about the growing prevalence of oral and subcutaneous injection oncology medications, which is shifting the delivery of care from the clinic to at-home. This innovation in cancer care introduces complexities around accessing and affording t…
…
continue reading
1
Navigating the Complexities of Access to Specialty Medications with Chelsey Lindner Shields Health Solutions
19:53
19:53
Play later
Play later
Lists
Like
Liked
19:53
Chelsey Lindner, a pharmacist and Manager of Clinical Services at Shields Health Solutions, provides insights about the growing prevalence of oral and subcutaneous injection oncology medications, which is shifting the delivery of care from the clinic to at-home. This innovation in cancer care introduces complexities around accessing and affording t…
…
continue reading
1
Transforming Cough Analysis and Respiratory Healthcare Through AI and Digital Therapeutics with Tamsin Chislett Hyfe TRANSCRIPT
Tamsin Chislett, CEO of Hyfe, highlights the importance of understanding coughs for healthcare providers, the lack of information about coughs, and Hyfe's advancements in building a database and developing biomarkers based on different kinds of coughs. Hyfe's AI technology, which can integrate with other devices and platforms for remote patient mon…
…
continue reading
1
Transforming Cough Analysis and Respiratory Healthcare Through AI and Digital Therapeutics with Tamsin Chislett Hyfe
18:40
18:40
Play later
Play later
Lists
Like
Liked
18:40
Tamsin Chislett, CEO of Hyfe, highlights the importance of understanding coughs for healthcare providers, the lack of information about coughs, and Hyfe's advancements in building a database and developing biomarkers based on different kinds of coughs. Hyfe's AI technology, which can integrate with other devices and platforms for remote patient mon…
…
continue reading
1
How Digital Tools are Addressing Nurse Burnout and Retention with Geoff Nau Altera Digital Health TRANSCRIPT
Geoff Nau, Senior Manager of Product Management for Paragon at Altera Digital Health, highlights how digital health solutions can address the challenges of nurse burnout and retention. AI and machine learning can help automate documentation tasks and streamline workflows to allow nurses better access to patient information. Improving nurse retentio…
…
continue reading
1
How Digital Tools are Addressing Nurse Burnout and Retention with Geoff Nau Altera Digital Health
21:55
21:55
Play later
Play later
Lists
Like
Liked
21:55
Geoff Nau, Senior Manager of Product Management for Paragon at Altera Digital Health, highlights how digital health solutions can address the challenges of nurse burnout and retention. AI and machine learning can help automate documentation tasks and streamline workflows to allow nurses better access to patient information. Improving nurse retentio…
…
continue reading
1
Multispecific Antibodies and Antibody Drug Conjugates for Hard-to-Treat Cancers and Autoimmune Diseases with Dr. Paul Moore Zymeworks TRANSCRIPT
Dr. Paul Moore, Chief Scientific Officer at Zymeworks, focuses on developing targeted therapies, particularly multispecific antibodies and antibody-drug conjugates for hard-to-treat cancers such as gynecological, thoracic, and digestive tract cancers. This approach can target multiple areas on tumor cells and immune cells, potentially overcoming tu…
…
continue reading
1
Multispecific Antibodies and Antibody Drug Conjugates for Hard-to-Treat Cancers and Autoimmune Diseases with Dr. Paul Moore Zymeworks
19:51
19:51
Play later
Play later
Lists
Like
Liked
19:51
Dr. Paul Moore, Chief Scientific Officer at Zymeworks, focuses on developing targeted therapies, particularly multispecific antibodies and antibody-drug conjugates for hard-to-treat cancers such as gynecological, thoracic, and digestive tract cancers. This approach can target multiple areas on tumor cells and immune cells, potentially overcoming tu…
…
continue reading
1
Care Orchestration Optimizing Provider Capacity and Access to Care with Dr. Sonja Tarrago DexCare TRANSCRIPT
Dr. Sonja Tarrago, head of Physician Strategy and Engagement at DexCare, has created a care orchestration platform to help health systems improve patient access to care, direct patients to the proper care, and optimize provider capacity. DexCare solutions have enabled health systems to treat more patients with existing resources, increase new patie…
…
continue reading
1
Care Orchestration Optimizing Provider Capacity and Access to Care with Dr. Sonja Tarrago DexCare
19:44
19:44
Play later
Play later
Lists
Like
Liked
19:44
Dr. Sonja Tarrago, head of Physician Strategy and Engagement at DexCare, has created a care orchestration platform to help health systems improve patient access to care, direct patients to the proper care, and optimize provider capacity. DexCare solutions have enabled health systems to treat more patients with existing resources, increase new patie…
…
continue reading
1
Using AI to Tackle Demands of the Clinical Inbox Reducing Doctor Burnout with David Norris Affineon TRANSCRIPT
David Norris, Founder and CEO of Affineon Health Inc., recognizes the significant problem of provider burnout, which is primarily caused by the time doctors spend on administrative tasks rather than with the patient. Affineon's AI-powered solution aims to address this by automating the review of the provider's inbox and reducing their cognitive loa…
…
continue reading
1
Using AI to Tackle Demands of the Clinical Inbox Reducing Doctor Burnout with David Norris Affineon
20:48
20:48
Play later
Play later
Lists
Like
Liked
20:48
David Norris, Founder and CEO of Affineon Health Inc., recognizes the significant problem of provider burnout, which is primarily caused by the time doctors spend on administrative tasks rather than with the patient. Affineon's AI-powered solution aims to address this by automating the review of the provider's inbox and reducing their cognitive loa…
…
continue reading
1
Using Pulse Electric Field and Direct Tumor Injections to Target Advanced Cancers with Dr. Jason Williams The Williams Cancer Institute TRANSCRIPT
Dr. Jason Williams, President and Director of Interventional Oncology and Immunotherapy at the Williams Cancer Institute, uses a combination of Pulse Electric Field technology to ablate tumors and direct injection of immunotherapy drugs into the tumor to stimulate the immune system. This approach can be used in conjunction with traditional cancer t…
…
continue reading
1
Using Pulse Electric Field and Direct Tumor Injections to Target Advanced Cancers with Dr. Jason Williams The Williams Cancer Institute
17:41
17:41
Play later
Play later
Lists
Like
Liked
17:41
Dr. Jason Williams, President and Director of Interventional Oncology and Immunotherapy at the Williams Cancer Institute, uses a combination of Pulse Electric Field technology to ablate tumors and direct injection of immunotherapy drugs into the tumor to stimulate the immune system. This approach can be used in conjunction with traditional cancer t…
…
continue reading
Joel Stanley is the CEO of Ajna Biosciences, a company developing the next generation of botanical medicines. These full-spectrum drugs, derived from plants and fungi, are regulated and approved through the FDA, unlike dietary supplements. Lead drug candidates are targeting autism, generalized anxiety disorder, and PTSD. With expertise in cultivati…
…
continue reading
1
Next-Generation Full-Spectrum Botanical Medicines with Joel Stanley Ajna Biosciences
22:42
22:42
Play later
Play later
Lists
Like
Liked
22:42
Joel Stanley is the CEO of Ajna Biosciences, a company developing the next generation of botanical medicines. These full-spectrum drugs, derived from plants and fungi, are regulated and approved through the FDA, unlike dietary supplements. Lead drug candidates are targeting autism, generalized anxiety disorder, and PTSD. With expertise in cultivati…
…
continue reading
1
Role for AI-Enhanced Screening in Early Detection of Breast Cancer with Dana Brown iCAD TRANSCRIPT
Dana Brown serves as President, CEO, and Chairman of the Board at iCAD Inc., which has developed a next-generation approach that leverages advancements in AI and imaging technology to improve the accuracy and efficiency of breast cancer screening. This technology can help reduce unnecessary biopsies and additional tests while more accurately identi…
…
continue reading
1
Role for AI-Enhanced Screening in Early Detection of Breast Cancer with Dana Brown iCAD
19:00
19:00
Play later
Play later
Lists
Like
Liked
19:00
Dana Brown serves as President, CEO, and Chairman of the Board at iCAD Inc., which has developed a next-generation approach that leverages advancements in AI and imaging technology to improve the accuracy and efficiency of breast cancer screening. This technology can help reduce unnecessary biopsies and additional tests while more accurately identi…
…
continue reading
1
Early Detection of Alzheimer’s Protein Biomarker with Home Blood Test with Dr. Rany Aburashed Neurogen Biomarking TRANSCRIPT
Dr. Rany Aburashed, CEO and Founder of Neurogen Biomarking, is using a blood-based biomarker looking at p-tau 217 to detect early signs of Alzheimer's disease, up to 8-10 years before the onset of clinical symptoms. The company has built an ecosystem to provide patients with a comprehensive health assessment with an at-home blood test, cognitive te…
…
continue reading
1
Early Detection of Alzheimer’s Protein Biomarker with Home Blood Test with Dr. Rany Aburashed Neurogen Biomarking
26:41
26:41
Play later
Play later
Lists
Like
Liked
26:41
Dr. Rany Aburashed, CEO and Founder of Neurogen Biomarking, is using a blood-based biomarker looking at p-tau 217 to detect early signs of Alzheimer's disease, up to 8-10 years before the onset of clinical symptoms. The company has built an ecosystem to provide patients with a comprehensive health assessment with an at-home blood test, cognitive te…
…
continue reading
1
Impact of Integrating AI into Behavioral Health Workflow and Patient Engagement with Ram Krishnan Valant TRANSCRIPT
Ram Krishnan, CEO of Valant, uses AI to make mental health care more accessible through their practice management and patient engagement platforms designed specifically for mental health providers. AI is applied to improve administrative efficiency, address billing and compliance, and drive successful patient outcomes. New solutions are needed due …
…
continue reading
1
Impact of Integrating AI into Behavioral Health Workflow and Patient Engagement with Ram Krishnan Valant
21:11
21:11
Play later
Play later
Lists
Like
Liked
21:11
Ram Krishnan, CEO of Valant, uses AI to make mental health care more accessible through their practice management and patient engagement platforms designed specifically for mental health providers. AI is applied to improve administrative efficiency, address billing and compliance, and drive successful patient outcomes. New solutions are needed due …
…
continue reading
1
Organ Preservation Technology Transforming Organ Transplantation with Jaya Tiwari XVIVO TRANSCRIPT
Jaya Tiwari, Senior Vice President of Clinical and Regulatory Affairs at XVIVO, which is focused on improving organ preservation for transplantation. Current organ preservation methods using ice coolers limit the time and distance organs can be transported. XVIVO's perfusion technology can significantly extend the preservation time of hearts, kidne…
…
continue reading
1
Organ Preservation Technology Transforming Organ Transplantation with Jaya Tiwari XVIVO
17:38
17:38
Play later
Play later
Lists
Like
Liked
17:38
Jaya Tiwari, Senior Vice President of Clinical and Regulatory Affairs at XVIVO, which is focused on improving organ preservation for transplantation. Current organ preservation methods using ice coolers limit the time and distance organs can be transported. XVIVO's perfusion technology can significantly extend the preservation time of hearts, kidne…
…
continue reading
